arginine vasopressin has been researched along with iberiotoxin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hill, CE; Kirton, A; Vanner, SJ; Wu, DD | 1 |
Isono, K; Kondo, M; Nagai, A; Tagaya, E; Tamaoki, J; Yamawaki, I | 1 |
2 other study(ies) available for arginine vasopressin and iberiotoxin
Article | Year |
---|---|
Role of maxi-K+ channels in endothelin-induced vasoconstriction of mesenteric and submucosal arterioles.
Topics: Animals; Arginine Vasopressin; Arterioles; Dinoprost; Endothelin Receptor Antagonists; Endothelin-1; Endothelin-3; Endothelins; Guinea Pigs; Ileum; Intestinal Mucosa; Kinetics; Large-Conductance Calcium-Activated Potassium Channels; Male; Membrane Potentials; Mesenteric Arteries; Muscle, Smooth; Muscle, Smooth, Vascular; Norepinephrine; Peptide Fragments; Peptides; Peptides, Cyclic; Potassium Channels; Potassium Channels, Calcium-Activated; Receptor, Endothelin A; Scorpion Venoms; Tetraethylammonium; Time Factors; Vasoconstriction | 1997 |
A human bronchial epithelial cell line releases arginine vasopressin: involvement of Ca2+ -activated K+ channels.
Topics: Arginine Vasopressin; Bradykinin; Bronchi; Carbamates; Cell Line; Epithelial Cells; Humans; Large-Conductance Calcium-Activated Potassium Channels; Peptides; Phenylcarbamates; Platelet Activating Factor; Potassium Channel Blockers; Potassium Channels, Calcium-Activated; Type C Phospholipases | 1998 |